“…The PLCζ mutations identified from such patients were predicted to modify the enzyme fold, abrogating sperm PLCζ [ 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 ]. Reduced/absent PLCζ is indicative of OAD sperm [ 1 , 13 , 16 , 18 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 ], with PLCζ deficiencies increasingly associated with multiple male-specific conditions [ 1 , 16 , 18 , 22 , 23 , 24 , 25 , 26 , 27 , 28 ]. Recently, using two antibodies with demonstrable specificity for PLCζ, Kashir et al [ 30 ] demonstrated that higher levels and specific localisation patterns of PLCζ in human sperm correlated to the optimal ranges of sperm fertility parameters, and higher proportions of successful fertilisation in a general population of males undergoing fertility treatment.…”